CBIS has initiated a 250-Acre Industrial Hemp Project that allows for an all-inclusive Economic...
There are no announcements yet.
Cannabis Science's North American Economic Development Initiative has successfully launched the Native American Agriculture Initiative Plan; 2017 CBIS/FSO NAC MBS. Together with Free Spirt Organics Native American Corporation, HRM Farms, Raymond C. Dabney University (RCDU), and American States University’s (ASU) Department of Agriculture, Cannabis Science has initiated a 250-Acre Industrial Hemp Project that allows for an all-inclusive Economic Development Plan in San Joaquin County.
ASU and RCDU provide affordable and flexible education to the Native American community, and the city of Stockton. These Universities specialize in entrepreneurial and agricultural programs and offer scholarship opportunities. A key area of this economic development plan is job creation, and CBIS has provided many jobs to the community from the University site creation and Hemp Farm cultivation. Furthermore, vertical integration allows for jobs to be provided through the development of local industrial hemp industry, healthcare infrastructure, water management, waste management, technology, communications, and housing. CBIS and its partners intend to pass on any business opportunities related to hemp cultivation research and development to the citizens of San Joaquin County.
EDUCATION
RCDU is a compliment to a California online university that provides live seminars and workshops presented by a dedicated and experienced faculty of law professors. They offer general educational development designed to take you to the forefront of your profession. The curriculum delivers foundational knowledge and real-world skills to immediately prepare their students for their career. RCDU provides the financial and managerial resources needed for a non-traditional education, in the fields of law, business, and healthcare.
ASU offers a combined thirty-seven state-approved certification and degree programs housed within five departments. Its primary purpose is to provide professional training in agricultural hemp research and development for pharmaceutical drugs targeting critical ailments such as Cancer, Epilepsy, Chronic Pain, Parkinson's Disease, Arthritis, PTSD, HIV/AIDs and other industries such as Alternate Biofuels, Construction, and Clothing and Automobile Materials. American States University has 5 main Education Initiatives:
PROVIDING HYBRID FOCUSED INTERACTIVE TRAINING
Online, in class, and in the field training gives our students the flexibility and hands-on education to learn their trade.
EMPHASIZING PRACTICAL ENTREPRENEURIAL EDUCATION
Students leave American States University with skills to create jobs in the community, not just look for jobs.
OFFERING AFFORDABLE AND EASY ACCESS TO EDUCATION
ASU's unique hybrid education model allows for courses at a low priced rate. Scholarships and subsidized packages are available to qualifying students.
TARGETING DISTRESSED COMMUNITIES
Affordable and entrepreneurial education means ASU can help struggling communities build themselves up.
SPECIALIZING IN R&D OF INDUSTRIAL HEMP
This is a massive, growing, and untapped industry that will directly benefit its participants through job creation and revenue streams.
JOB CREATION
Vertical integration allows Cannabis Science to provide many jobs throughout the community in agriculture, education, healthcare training, construction, and general retail services:
Job creation due to Universities and site services including laboratory facilities for research & development
Job creation due to students graduating from Universities with entrepreneurial skills to create their own jobs
Academic and vocational training, covering each applied industry;
Agricultural research
Development of industrial hemp industry
Development of healthcare infrastructure, including hospitals and health centers
Pharmaceutical and Alternative Medicines development
Creation of a sustainable, food security system that is based on sound agricultural practices that produce sufficient food for consumption and that are designed to reduce poverty and allow for real farm-to-table programs
Development of water management systems
Development of waste management systems that reduce the prevalence of critical risk factors for infectious diseases
Investment in communications infrastructure, to include satellite, internet, mechanical device development, and cell phone infrastructure; and
Support for policy, regulatory, and jurisdictional environments, as they pertain to public healthcare, agriculture, education, job creation, and most important; on the job training oriented for success
And other other key fundamentals depending on the demographics such as housing, apartments, dormitories, and retail services; restaurants, gas stations, grocery stores, clinics, pharmacies, and retail strip malls.
DRUG DEVELOPMENT
Cannabis Science is in partnership with ASU, Free Spirit Organics Native American Corporation, HRM Farms, AECG and RCDU to conduct a Native American Agriculture Initiative Plan; 2017 CBIS/FSO NAC MBS. This plan focuses on cannabinoid drug development using proven extraction methodologies derived from the Industrial Hemp plant, targeting critical ailments such as Cancer, PTSD, Chronic Pain, Arthritis, Parkinson’s Disease, Epilepsy, Autism, and HIV/AIDS. Cannabis Science has three main steps to execute the cannabinoid drug development:
Define the effectiveness and specificity of cannabinoids.
Identify and test drug delivery mechanisms.
Test and evaluate the impact of co-interventions, and the application of additional diagnostic and/or therapeutic procedures to participants in randomized controlled trials.
From here, 3 target markets will be sought after:
FDA – Dr. written prescriptions for target critical ailments.
Over the counter – Nutraceutical and cosmeceuticals.
State by State Initiatives – Regulation, cultivation, laboratory, manufacturing, and distribution.
It is estimated that there will be $450 million US Hemp based CBD product sales in 2020, with 40% of that being pharmaceuticals. The creation of cannabinoid drugs will benefit those twofold; by bringing a financial increase to the parties and communities involved, and by increasing the overall social well-being of the community.
Recent GBXI News:
May 11, 2023, GBX International Group, Inc., (OTC: GBXI)
GBX International Group, Inc. (OTC:GBXI) Confirms 2023 Strong Revenue Growth Guidance Projections by Combining Each Acquired Operating Company Product Release, Expects Strong Growth Sector by Sector Through its Multiple Product Releases into North American and International Markets
April 21, 2023, GBX International Group, Inc., (OTC: GBXI)
HARVARD Award Winning Entrepreneur, Mr. Raymond C. Dabney Acquires Majority Shareholder Control of GBX International Group, Inc. (OTC: GBXI) Makes More History Bringing CSi-EDP Partner American States University (ASU) as the First Acquisition for its Aggressive Growth Plans
The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.
Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.
We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.
Click here to review the Report:
Case No. 2:17-CV-02271-KJM-JDP
Inspire, Dream, Change
YOUR DIGITAL ERA Personal & Business Access Learning HUB
Hi Raymond,
As a long-standing Loyal Shareholder, I hope that this posting finds you in good health and good spirits. I made my first CBIS purchase...Hi Raymond,
As a long-standing Loyal Shareholder, I hope that this posting finds you in good health and good spirits. I made my first CBIS purchase in Sept 2014 (Dr. Bob was still at CBIS) and I made my last purchase in June 2017; just prior to the Hemp Seizure that F'k-up everything for CBIS going forward.
BUT, on 2017-01-09 CBIS Entered into 1 yr. Research Collaboration Agreement (RCA) with Dana Farber Cancer Institute (DFCI) to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers.
Then on 2018-01-18 1st Frontiers In Oncology Article: "Nano Particle Drone to Target Lung Cancer with Radio Sensitizers & Cannabis." - KILLING CANCER
And then again on 2018-02-02 CBIS expanded the RCA with DFCI for 5 yrs. (@ $1.8M) to develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers. That RCA agreement expired on 2023-02-02.
NOW, On 2023-02-02 the Expanded RCA with DFCI has ended. THE RESULTS ARE NOW KNOWN:
For the $1.8mil investment with DFCI, several Cancer Killing Formulations have been developed.
#1-6 Represents the drug formulations developed by DFCI during the 5yr RCA for treatment of the following cancers:
1. Skin Cancer
2. Breast Cancer
3. Brain Cancer
4. Kaposi's Sarcoma
5. Lung Cancer
6. Pancreatic Cancer
7. CBN Patent Valuation
#7 is the US Patent that was awarded to CBIS which describes the formulation used to treat certain neurological ailments such as ODD, ADD, etc.
On 2023-05-08 it was announced that GBXI signs the first 3 acquisitions for the GBXI Conglomerate (follow link below for details)
finance.yahoo.com/news/gbxi-advances-forward-signs…
Then On 2023-12-13 you posted the following: "GBXI Corporate Filings, Financials, and trading status has been delayed due to change of control filings and approvals. The Company has several options on the list for trading resumption as it pursues its regulatory approvals. The Company is pursuing the fastest path to trading first and will proceed down the list as it moves towards its ultimate goal of bringing all the GBXI conglomerate company shares back trading again.
QUESTION: Where are we toward the completion of this process?? 50% / 75% / 90% ????
--------
Some info that the I have found about a SPAC is as follows:
When does a SPAC become public?
--------------------------------------------
These types of transactions, most commonly where a SPAC acquires or merges with a private company, occur after, often many months or more than a year after, the SPAC has completed its own IPO. Unlike an operating company that becomes public through a traditional IPO, however, a SPAC is a shell company when it becomes public.
Period to consummate the initial business combination.
--------------------------------------------------------------------
A SPAC will typically provide for a two-year period to identify and complete an initial business combination transaction. However, some SPACs have opted for shorter periods, such as 18 months. The SPAC’s governing instruments may permit it to extend that time period. If a SPAC seeks to extend the time period, it may be required to seek shareholder approval. If a SPAC lists its securities on an exchange, it is required to complete an initial business combination within three years of its IPO. IPO proceeds are held in the trust account until a SPAC consummates a business combination or liquidates. If the SPAC is liquidated, shareholders at the time of the liquidation will be entitled to their pro rata share of the aggregate amount then on deposit in the trust account.
On 2023-11-08 an independent entity named Capizate, Inc.; prepared and presented a "Situation Analysis of the GBX International Group" which provided a list of Strengths, Areas of Improvements, and a Cancer Drug Valuation of just one of the drug formulations noted above ($25Mil-$29Mil) - Impressive.
However, here is the list that I have concern for; can't go PUBLIC without being fixed:
Areas for improvement
----------------------------
1. The business documents, agreements, term sheets, engagements are all dated in 2017-2018 and need to be updated.
2. Ownership and control of the intellectual property needs to be defined and confirmed.
3. A similar entity has active registration with California Secretary of State. The Company has a different address than on the Company website and also had a Statement of Info due to the California Secretary of State on 05/10/2023. Registered with the California Secretary of State as a Non-Profit Nonprofit Corporation - CA - Mutual Benefit. This will need to be defined.
QUESTIONS:
---------------
(1) Who's working on updating documentation? What's the % complete?
(2) Who owns and/or controls the CBIS Intellectual Property?
(3) is there another entity out there using the same name as Cannabis Science?
(4) WHERE IS BRINGING CBIS BACK PUBLIC AGAIN ON YOUR LIST OF PRIORITIES?
Thank you Raymond in advance of your response.
Best Regards
Show more
Cannabis Science CEO, Presents …
The FINAL “CBIS GIFT Shares” Issuances!
DECEMBER 1, 2022, Cheers! & HAPPY HOLIDAYS !!!
ALL GIFT Shares 1, 2, & 3 being ISSUED !!!
LAST Steps:
Please confirm Yours NOW !!!
1. CONFIRM Correct Total Share Amount(s)
2. CONFIRM Correct Name(s) on CERTIFICATE
3. CONFIRM Correct Mailing Address
ASU/CSi-EDP-ECO-System
At it's FINEST !!!
WHICH ONE ARE YOU ??
Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???
We can make this HAPPEN way FASTER Working as a TEAM !!!
WHAT Matters is how much you CARE about KILLING CANCERS ...
This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.
2023 Audit considerations NASDAQ.
Cannabis Science Inc.
Share Structure 2023
Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.
Common Stock:
Authorized:
5,000,000,000
Issued:
2,521,095,296
Class A Common Stock
Authorized:
100,000,000
Issued:
0
Class B Common Stock
Authorized:
1,500,000,000
Issued:
0
Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000
Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.
You already know our Extensive LIST of GROUNDBREAKING Products.
1-Million STRONG TV Coverage, HARVARD Award Success.
TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE
*** APPLY for FREE in CONFIDENCE and Success.
Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.
EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!
1. Original CBIS, everyone has... Show more 4 weeks ago
“We... Show more 4 weeks ago